Abstracts

303 – Factors Associated With Detectable Viral Load Among PLHIV in Serodiscordant Partnerships in Tanzania

Background People living with HIV (PLHIV) with undetectable HIV viral load (VL) cannot sexually transmit HIV to others. Forthcoming clinical guidelines in Tanzania define full HIV VL suppression as <50 copies/mL. PLHIV with detectable VL (DVL) in serodiscordant (SD) marriages or cohabiting relationships (SD-PLHIV) are at increased risk of transmitting HIV to their partner without HIV. Using data from a…

164 – The Doxy-PEP Continuum Among Patients Receiving Care at a Sexual Health Clinic in San Francisco

Background In 2024, San Francisco Department of Public Health released updated recommendations for prescribing doxycycline post-exposure prophylaxis (doxy-PEP). These matched CDC guidance and additionally encouraged shared decision-making between providers and patients with at least 2 sex partners in the last year who were assigned male sex at birth. San Francisco AIDS Foundation’s Magnet Clinic, a…

320 – Fatty Acid Synthesis Controls Both Cellular Susceptibility to HIV and New Particle Production

Background As an obligate intracellular pathogen, HIV must hijack resources from infected host cells to support the viral lifecycle. While this includes a viral dependency on host metabolism, little is known about the specific metabolic networks that are essential for infection and viral replication. Previous work leveraging a single-cycle reporter virus has established that blocking…

309 – ScRNA-seq of HRSV/SARS-CoV-2 Co-Infection Reveals Unique Cellular Responses and lncRNA Signatures

Background Respiratory co-infections caused by HRSV and SARS-CoV-2 often result in severe respiratory disease, but the underlying cellular/molecular mechanisms are poorly understood. Using an in vitro model of HRSV/SARS-CoV-2 co-infection, we investigated how individual cells respond to simultaneous or single infections, providing insights into synergistic/antagonistic viral interactions. Methods Single-cell RNA sequencing (scRNA-seq) data of the…

312 – Genetic Mutation Differences Patterns of SARS-CoV-2 in Immunocompromised Patients Versus Controls

Background Although documented, the mutational dynamics of SARS-CoV-2 in immunocompromised patients remain relatively understudied. This study examined a cohort of immunocompromised patients hospitalized with SARS-CoV-2 infection to assess the distinct evolutionary trajectories of SARS-CoV-2 in these individuals compared to their immunocompetent counterparts. We compared the genetic diversity of SARS-CoV-2 between these groups over time. Methods…

322 – Functional Study of N6-Methyladenosine (m6A) Machinery in HIV Infection of Primary CD4+ T Cells

Background N6-methyladenosine (m6A) modification is the most prevalent post-transcriptional modification of cellular and viral RNA and is critical to the regulation of its localization, stability, and translation. The core m6A machinery consists of writers that deposit the modification, erasers that remove it and readers that respond to the presence of m6A on RNA. Previous studies…

328 – The Role of Capsid-Host Interaction on Lentiviral Evolution

Background Primate lentiviruses (SIVs) have been evolving with their hosts for millions of years. Capsid-interacting dependency and restriction factors are known to play a key role in HIV replication. Small changes in viral capsid sequence can alter these interactions for the benefit of the virus (e.g. to escape a restriction factor). Previous work has focused…